Table 2.
Nanoparticle effects on oxidative stress and stress response pathways.
Type of Nanoparticle | Experimental Model | Protein(s) Affected | Main Findings | References |
---|---|---|---|---|
Ag | n/a | CAT and SOD | Conformational changes to CAT resulting in loss of catalytic activity, but minimal effects to SOD shape and activity | [69] |
Ag | HaCaT and A549 | Thioredoxin reductase | Decreased expression of selenoproteins | [70] |
Ag and Ag+ | HepG2 and human hepatocytes | PRDXs, GST, myosin, elongation fac-tor 1, 60S ribosomal protein, and 40S ribosomal protein | Direct binding | [71] |
CdTe quantum dots | n/a | GPx3 | Direct binding through Van der Waals’ forces and hydrogen bonding, resulting in structural changes with increased alpha helical content | [72] |
CdTe quantum dots | n/a | GPx3 | Interactions with glutamate 136, phenylalanine 132, proline 130, and valine 129 in the GPx3 active site | [73] |
4Cu and CuO | RAW264.7 | PRDX1, PRDX2, PRDX3, and PRDX6 | Increased protein levels of the oxidized form of PRDX1 and the native form of PRDX6, with no change in the levels of PRDX2 and PRDX3 | [74] |
r/aTiO2, rTiO2 silica-coated, rTiO2 alumina-coated, aTiO2, and mwCNT | Human lung epithelial cells and human monocyte-derived macrophages | PRDXs | Association of the nanoparticles with PRDXs | [75] |
Selenium-Lovastatin | Female albino rats | Se-dependent GPx | Increased enzyme activity | [76] |
TiO2 | n/a | CAT and SOD | Conformational and functional changes with an increase in alpha helical content and increased exposure of hydrophobic regions | [77] |
Pb2+, Hg2+, Cd2+, Fe3+, Cu2+, Al3+ | n/a | Human erythrocyte GR | Competitively inhibited by Pb2+, Hg2+, Cd2+, Fe3+; and non-competitively inhibited by Cu2+ and Al3+ | [78] |
ZnO | Male C57BL/6 mouse liver | PDI-3 | Increased PDI-3 gene expression | [79] |
ZVFe | Human lymphocytes | Hb | Heme displacement and degradation, and induction of protein carbonylation | [80] |